{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:19:06Z","timestamp":1791559146227,"version":"4.3.4"},"reference-count":114,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder specific to pregnancy, typically presenting in the third trimester. It is characterized by pruritus, elevated serum bile acids, and abnormal liver function tests. While maternal symptoms resolve postpartum, ICP poses significant risks to fetal health, including spontaneous preterm labor, meconium-stained amniotic fluid, and stillbirth. This review aims to synthesize current knowledge on the pathogenesis, diagnosis, and management and highlight emerging research and possible therapy directions in ICP. A comprehensive review of recent literature was conducted, focusing on molecular mechanisms, clinical management guidelines, fetal outcomes, and novel therapeutics under investigation. Ursodeoxycholic acid (UDCA) remains the primary pharmacologic treatment of intrahepatic cholestasis of pregnancy; however, its effect on perinatal outcomes is debated. Investigational therapies\u2014including Volixibat, FXR agonists, 4-phenylbutyrate, and NorUDCA\u2014are under exploration. These emerging therapies hold the potential to improve both maternal symptoms and perinatal outcomes by addressing the underlying pathophysiology of ICP more effectively than current standard treatment. Additionally, emerging biomarkers and machine-learning tools hold promise for improved diagnosis and personalized care. ICP continues to pose diagnostic and therapeutic challenges. While maternal outcomes are generally favorable, optimizing fetal safety requires timely diagnosis, stratified risk assessment, and evidence-based delivery planning. Future research should prioritize identifying predictive biomarkers, refining treatment algorithms, and assessing long-term outcomes for both mothers and offspring. Special attention should also be given to the investigation of novel therapeutic targets.<\/jats:p>","DOI":"10.3390\/diagnostics15162002","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:10:32Z","timestamp":1754899832000},"page":"2002","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intrahepatic Cholestasis of Pregnancy: Diagnosis, Management, and Future Directions\u2014A Review of the Literature"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-5782","authenticated-orcid":false,"given":"Kamil","family":"Jasak","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Gajzlerska-Majewska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoulikha","family":"Jabiry-Zieniewicz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Litwi\u0144ska-Korcz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Litwi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-8661","authenticated-orcid":false,"given":"Artur","family":"Ludwin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-0319","authenticated-orcid":false,"given":"Monika","family":"Szpota\u0144ska-Sikorska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2015.11.030","article-title":"Pregnancy and liver disease","volume":"64","author":"Westbrook","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1080\/14767058.2021.1988924","article-title":"Intrahepatic cholestasis of pregnancy: Risk factors for severe disease","volume":"35","author":"Mashburn","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cld.398","article-title":"Intrahepatic cholestasis of pregnancy: Diagnosis and management","volume":"4","author":"Bacq","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.12659\/MSM.907723","article-title":"Liver Disease During Pregnancy: A Challenging Clinical Issue","volume":"24","author":"Mikolasevic","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_6","first-page":"e10540","article-title":"Never Too Soon: An Unusual Case of Intrahepatic Cholestasis of Pregnancy at Five Weeks Gestation","volume":"12","author":"Wongjarupong","year":"2020","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"Dixon","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): A randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S2468-1253(21)00074-1","article-title":"Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: A systematic review and individual participant data meta-analysis","volume":"6","author":"Ovadia","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2023.06.036","article-title":"Risk of stillbirth in United States patients with diagnosed intrahepatic cholestasis of pregnancy","volume":"229","author":"Estin","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_13","first-page":"203","article-title":"Frequency of intrahepatic cholestasis of pregnancy in Punjab Pakistan: A single centre study","volume":"66","author":"Hafeez","year":"2016","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gao, X.X., Ye, M.Y., Liu, Y., Li, J.Y., Li, L., Chen, W., Lu, X., Nie, G., and Chen, Y.H. (2020). Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-73378-5"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jamshidi Kerachi, A., Shahlaee, M.A., Habibi, P., Dehdari Ebrahimi, N., Ala, M., and Sadeghi, A. (2025). Global and regional incidence of intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis. BMC Med., 23.","DOI":"10.1186\/s12916-025-03935-0"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/apt.70096","article-title":"Meta-Analysis: Pregnancies with Inflammatory Bowel Disease Complicated by Intrahepatic Cholestasis of Pregnancy","volume":"61","author":"Joudaki","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1080\/07853890.2022.2136400","article-title":"Prevalence, risk factors and adverse perinatal outcomes for Chinese women with intrahepatic cholestasis of pregnancy: A large cross-sectional retrospective study","volume":"54","author":"Wu","year":"2022","journal-title":"Ann. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.12669\/pjms.41.4.9578","article-title":"HBV infection and pregnancy: Increased risks of gestational diabetes and preterm birth","volume":"41","author":"Cai","year":"2025","journal-title":"Pak. J. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zou, K., Huang, S., Liu, C., Zhao, P., Guo, J., Wei, W., Chen, J., Yao, G., Qian, Y., and Rong, B. (2025). The impact of maternal HBeAg carries status and elevated ALT values on adverse outcomes: A population-based cohort study in 198,049 pregnancies. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07410-9"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.5937\/jomb0-50420","article-title":"Relationship between HBV RNA level and pregnancy outcomes among hepatitis B carriers","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Med. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ijgo.15878","article-title":"Comparing risk factors and neonatal outcomes in women with intrahepatic cholestasis of pregnancy between assisted reproductive technology and spontaneous conception","volume":"168","author":"Yang","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1080\/14767058.2020.1765331","article-title":"Intrahepatic cholestasis of pregnancy: Are in vitro fertilization pregnancies at risk?","volume":"34","author":"Yetkinel","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5005\/jp-journals-10018-1232","article-title":"Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization","volume":"7","author":"Bolukbas","year":"2017","journal-title":"Euroasian J. Hepatogastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s43032-023-01329-2","article-title":"Predictors of Adverse Fetal Outcomes in Intrahepatic Cholestasis of Pregnancy (ICP): A Narrative Review","volume":"31","author":"Obiegbusi","year":"2024","journal-title":"Reprod. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2023). EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. J. Hepatol., 79, 768\u2013828.","DOI":"10.1016\/j.jhep.2023.03.006"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clindermatol.2016.02.004","article-title":"Intrahepatic cholestasis of pregnancy: Recent advances","volume":"34","author":"Ovadia","year":"2016","journal-title":"Clin. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/aogs.12168","article-title":"Intrahepatic cholestasis of pregnancy is common among patients\u2019 first-degree relatives","volume":"92","author":"Turunen","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"667.e1","DOI":"10.1016\/j.ajog.2015.02.012","article-title":"The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age","volume":"212","author":"Puljic","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/cge.14728","article-title":"Intrahepatic Cholestasis of Pregnancy: A Single-Centre Whole-Exome Sequencing Study in a Maltese Cohort","volume":"108","author":"Spiteri","year":"2025","journal-title":"Clin. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liu, X., Lai, H., Xin, S., Li, Z., Zeng, X., Nie, L., Liang, Z., Wu, M., Zheng, J., and Zou, Y. (2021). Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: A case-control study. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-03595-x"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Liu, X., Zheng, J., Xin, S., Zeng, Y., Wu, X., Zeng, X., Lai, H., and Zou, Y. (2022). Whole-exome sequencing expands the roles of novel mutations of organic anion transporting polypeptide, ATP-binding cassette transporter, and receptor genes in intrahepatic cholestasis of pregnancy. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.941027"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","article-title":"Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy","volume":"133","author":"Milona","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Piechota, J., and Jelski, W. (2020). Intrahepatic Cholestasis in Pregnancy: Review of the Literature. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051361"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Marin, L., Ambrosini, G., Nuzzi, L., Buzzaccarini, G., Esposito, F., Capobianco, G., Chiantera, V., Lagan\u00e0, A.S., and Andrisani, A. (2023). Intrahepatic cholestasis of pregnancy after ovarian hyperstimulation syndrome with wild-type ABCB4 gene: A peculiar case and literature review. BMC Womens Health, 23.","DOI":"10.1186\/s12905-023-02471-4"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1055\/a-2081-2573","article-title":"Vaginal Progesterone Is Associated with Intrahepatic Cholestasis of Pregnancy","volume":"40","author":"Tsur","year":"2023","journal-title":"Am. J. Perinatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Verma, A., Kumar, I., Kumari, A., Pandey, U., and Singh, P.K. (Abdom. Radiol., 2025). The impact of gallbladder motility in intrahepatic cholestasis of pregnancy: A prospective observational study, Abdom. Radiol., in press.","DOI":"10.1007\/s00261-025-04986-w"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"118010","DOI":"10.1016\/j.ecoenv.2025.118010","article-title":"Associations between fine particulate matter and its constituents and intrahepatic cholestasis of pregnancy","volume":"293","author":"Li","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114345","DOI":"10.1016\/j.envres.2022.114345","article-title":"Interactive effects of ambient air pollution and sunshine duration on the risk of intrahepatic cholestasis of pregnancy","volume":"215","author":"Li","year":"2022","journal-title":"Environ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e4683","DOI":"10.1002\/fsn3.4683","article-title":"Genetically Predicted Gut Microbiota Mediate the Association Between Fatty Acids and Intrahepatic Cholestasis of Pregnancy: A Mendelian Randomization Analysis","volume":"13","author":"Li","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Li, C., Li, N., Liu, C., and Yin, S. (2023). Causal association between gut microbiota and intrahepatic cholestasis of pregnancy: Mendelian randomization study. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05889-8"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/jcp.30774","article-title":"Autophagic flux inhibition, apoptosis, and mitochondrial dysfunction in bile acids-induced impairment of human placental trophoblast","volume":"237","author":"Yang","year":"2022","journal-title":"J. Cell Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10735-025-10427-1","article-title":"Mechanism of mitochondrial dysfunction on placental trophoblastic cells in intrahepatic cholestasis of pregnancy","volume":"56","author":"Huang","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cemortan, M., Sagaidac, I., and Cernetchi, O. (2025). Comparative analysis of vitamin K levels in women with intrahepatic cholestasis of pregnancy. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07515-1"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cemortan, M., Sagaidac, I., and Cernetchi, O. (2022). Assessment of vitamin K levels in women with intrahepatic cholestasis of pregnancy. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04875-w"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Luo, M., Wang, L., Yao, H., Wen, Y., Cao, D., Shen, W., and Liu, C. (2022). Diagnostic and prognostic value of blood inflammation and biochemical indicators for intrahepatic cholestasis of pregnancy in Chinese pregnant women. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-22199-9"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy","volume":"25","author":"Lee","year":"2008","journal-title":"Am. J. Perinatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(19)31870-0","article-title":"Elevations in skin tissue levels of bile acids in human cholestasis: Relation to serum levels and topruritus","volume":"73","author":"Ghent","year":"1977","journal-title":"Gastroenterology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8278(98)80207-9","article-title":"Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy","volume":"28","author":"Brites","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0950-3528(89)90011-0","article-title":"Jaundice in pregnancy","volume":"3","author":"Lunzer","year":"1989","journal-title":"Baillieres Clin. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0016-5085(87)90922-X","article-title":"Steatorrhea in patients with intrahepatic cholestasis of pregnancy","volume":"93","author":"Reyes","year":"1987","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhang, Q., Sheng, Y., Zhang, M., He, G., and Liu, X. (2025). Preterm birth and stillbirth: Total bile acid levels in intrahepatic cholestasis of pregnancy and outcomes of twin pregnancies: A retrospective cohort study from 2014 to 2022. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07644-7"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1111\/1471-0528.17206","article-title":"Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022","volume":"129","author":"Girling","year":"2022","journal-title":"BJOG"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/1471-0528.16669","article-title":"Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: Case\u2013control and cohort study","volume":"128","author":"Mitchell","year":"2021","journal-title":"BJOG"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: A randomized double-blind study controlled with placebo","volume":"27","author":"Palma","year":"1997","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ijgo.15016","article-title":"Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case-control study from a tertiary center","volume":"164","author":"Peker","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejogrb.2020.11.014","article-title":"First-trimester aspartate aminotransferase to platelet ratio index in predicting intrahepatic cholestasis in pregnancy and its relationship with bile acids: A pilot study","volume":"256","author":"Tolunay","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.22130","article-title":"Liver disease in pregnancy","volume":"47","author":"Hay","year":"2008","journal-title":"Hepatology"},{"key":"ref_59","first-page":"Cd000493","article-title":"Pharmacological interventions for treating intrahepatic cholestasis of pregnancy","volume":"7","author":"Walker","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: A meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int."},{"key":"ref_61","unstructured":"Pillarisetty, L.S., and Sharma, A. (2025, August 07). Pregnancy Intrahepatic Cholestasis, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551503\/."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hague, W.M., Callaway, L., Chambers, J., Chappell, L., Coat, S., de Haan-Jebbink, J., Dekker, M., Dixon, P., Dodd, J., and Fuller, M. (2021). A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: The TURRIFIC randomised trial. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-020-03481-y"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tjog.2023.09.001","article-title":"Pregnancy outcomes following antenatal screening for intrahepatic cholestasis of pregnancy (ICP)","volume":"62","author":"Obiegbusi","year":"2023","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"100.e1","DOI":"10.1016\/j.ajog.2014.07.026","article-title":"Intrahepatic cholestasis of pregnancy: Maternal and fetal outcomes associated with elevated bile acid levels","volume":"212","author":"Brouwers","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e4949","DOI":"10.1097\/MD.0000000000004949","article-title":"Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)","volume":"95","author":"Kong","year":"2016","journal-title":"Medicine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/cs1000363","article-title":"The bile acid taurocholate impairs rat cardiomyocyte function: A proposed mechanism for intra-uterine fetal death in obstetric cholestasis","volume":"100","author":"Williamson","year":"2001","journal-title":"Clin. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-2243(91)90222-7","article-title":"Vasoconstrictive effect of bile acids on isolated human placental chorionic veins","volume":"42","author":"Cruz","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2020.11.038","article-title":"Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations","volume":"74","author":"Vasavan","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100709","DOI":"10.1016\/j.ajogmf.2022.100709","article-title":"Trends in gestational age at delivery for intrahepatic cholestasis of pregnancy and adoption of society guidelines","volume":"4","author":"Lagon","year":"2022","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.70161","article-title":"FIGO guideline on liver disease and pregnancy","volume":"170","author":"Nana","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2021). Medically Indicated Late-Preterm and Early-Term Deliveries: ACOG Committee Opinion, Number 831. Obstet. Gynecol., 138, e35\u2013e39.","DOI":"10.1097\/AOG.0000000000004447"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tang, W.Z., Zhao, Y.F., Wang, L., Cai, Q.Y., Xu, W.Z., Wen, L., Chen, X.B., Sheng, T.H., Fan, T.Q., and Liu, T.H. (2025). Investigating the risks of late preterm and term neonatal morbidity across clinical subtypes of intrahepatic cholestasis of pregnancy. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1528705"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Parsaei, M., Dashtkoohi, M., Haddadi, M., Rashidian, P., Mansouri, Z., and Hantoushzadeh, S. (2024). The association of serum total bile acid levels with gestational diabetes mellitus: A systematic review and meta-analysis. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06954-6"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/aogs.13695","article-title":"Intrahepatic cholestasis of pregnancy and comorbidity: A 44-year follow-up study","volume":"98","author":"Turunen","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI68927","article-title":"Maternal cholestasis during pregnancy programs metabolic disease in offspring","volume":"123","author":"Papacleovoulou","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00404-012-2482-4","article-title":"Usefulness of fetal monitoring in intrahepatic cholestasis of pregnancy: A prospective study","volume":"286","author":"Suri","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5114\/ceh.2019.88616","article-title":"Outpatient versus inpatient follow-up for intrahepatic cholestasis of pregnancy","volume":"5","author":"Ozyuncu","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Guerra, M., Haye, M.T., Monta\u00f1o, I., Toro, V., and Maiz, N. (Am. J. Perinatol., 2025). Fetal TEI Index in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study, Am. J. Perinatol., in press.","DOI":"10.1055\/a-2555-3684"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e271221199505","DOI":"10.2174\/1573403X18666211227145856","article-title":"Fetal Cardiac Function: Myocardial Performance Index","volume":"18","author":"Oliveira","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/uog.14769","article-title":"Monitoring intrahepatic cholestasis of pregnancy using the fetal myocardial performance index: A cohort study","volume":"46","author":"Henry","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_81","first-page":"617","article-title":"Effect of Maternal Ursodeoxycholic Acid Treatment on Fetal Atrioventricular Conduction in Patients with Intrahepatic Cholestasis of Pregnancy","volume":"51","author":"Eyisoy","year":"2024","journal-title":"Fetal Diagn. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1080\/14767058.2018.1535588","article-title":"Assessment of fetal left ventricular modified myocardial performance index and its prognostic significance for adverse perinatal outcome in intrahepatic cholestasis of pregnancy","volume":"33","author":"Ozel","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14767058.2016.1190824","article-title":"Can fetal left ventricular modified myocardial performance index predict adverse perinatal outcomes in intrahepatic cholestasis of pregnancy?","volume":"30","author":"Sanhal","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Geenes, V., L\u00f6vgren-Sandblom, A., Benthin, L., Lawrance, D., Chambers, J., Gurung, V., Thornton, J., Chappell, L., Khan, E., and Dixon, P. (2014). The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083828"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"You, P., Ding, M., Li, X., Shao, Y., Jiang, T., Jia, Y., Wang, Y., and Zhang, X. (2025). Determining Urinary Bile Acid Profiles to Predict Maternal and Neonatal Outcomes in Patients with Intrahepatic Cholestasis of Pregnancy. Diagnostics, 15.","DOI":"10.3390\/diagnostics15060657"},{"key":"ref_86","first-page":"270","article-title":"Characteristics and diagnostic value of serum bile acids profile in pregnant women with intrahepatic cholestasis of pregnancy and asymptomatic hypercholanemia of pregnancy","volume":"59","author":"Gou","year":"2024","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5603\/gpl.102459","article-title":"The role of the Systemic Inflammatory Response Index (SIRI) and other maternal biochemical markers in determining the severity of intrahepatic cholestasis of pregnancy","volume":"96","author":"Callioglu","year":"2025","journal-title":"Ginekol. Pol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"231211","DOI":"10.7754\/Clin.Lab.2023.231211","article-title":"Role of Systemic Immune Inflammatory Index to Predict Intrahepatic Cholestasis of Pregnancy","volume":"70","author":"Ergani","year":"2024","journal-title":"Clin. Lab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e13937","DOI":"10.1111\/aji.13937","article-title":"Are Systemic Inflammation Markers Reliable for Diagnosing Intrahepatic Cholestasis of Pregnancy? A Retrospective Cohort Study","volume":"92","author":"Aksan","year":"2024","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2024.0543","article-title":"Diagnostic Value of Neutrophil-to-Lymphocyte Ratio (NLR) in Intrahepatic Cholestasis of Pregnancy","volume":"86","author":"Ji","year":"2025","journal-title":"Br. J. Hosp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.15537\/smj.2024.45.11.20240760","article-title":"Systemic immune-inflammatory index and platelet-to-lymphocyte ratio in intrahepatic cholestasis of pregnancy","volume":"45","author":"Tuna","year":"2024","journal-title":"Saudi Med. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/1471-0528.16567","article-title":"Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: A secondary analysis of the PITCHES trial","volume":"128","author":"Fleminger","year":"2021","journal-title":"BJOG"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/01443615.2020.1820463","article-title":"Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels","volume":"41","author":"Deniz","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"G\u00fcvey, H., \u00c7elik, S., \u00c7al\u0131\u015fkan, C.S., Y\u0131lmaz, Z., Y\u0131lmaz, M., Erten, \u00d6., and Tinelli, A. (2021). How Do Serum Zonulin Levels Change in Gestational Diabetes Mellitus, Pregnancy Cholestasis, and the Coexistence of Both Diseases?. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182312555"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/01443615.2022.2114822","article-title":"Zonulin levels in complicated pregnancy: A systematic review and meta-analysis","volume":"42","author":"Daneshvar","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"104423","DOI":"10.1016\/j.jri.2025.104423","article-title":"Mechanisms underlying changes in intestinal permeability during pregnancy and their implications for maternal and infant health","volume":"168","author":"Ma","year":"2025","journal-title":"J. Reprod. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.hbpd.2019.12.001","article-title":"Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis","volume":"19","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"123716","DOI":"10.1016\/j.lfs.2025.123716","article-title":"Thyroid hormone ameliorates ursodeoxycholic acid-induced heart damage in zebrafish embryos","volume":"377","author":"Wu","year":"2025","journal-title":"Life Sci."},{"key":"ref_99","first-page":"S2049","article-title":"Efficacy, Safety and Tolerability of Volixibat in Patients with Intrahepatic Cholestasis of Pregnancy: A Case Series of 4 Patients","volume":"78","author":"Ovadia","year":"2023","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tips.2007.03.002","article-title":"FXR: A promising target for the metabolic syndrome?","volume":"28","author":"Cariou","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.placenta.2015.02.005","article-title":"Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta\u2014A study on maternal cholestasis model","volume":"36","author":"Wu","year":"2015","journal-title":"Placenta"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7419249","DOI":"10.1155\/2019\/7419249","article-title":"Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Sayin","year":"2016","journal-title":"Cell Metab."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Li, R., Chen, X., Liu, Z., Chen, Y., Liu, C., Ye, L., Xiao, L., Yang, Z., He, J., and Wang, W.J. (2020). Characterization of gut microbiota associated with clinical parameters in intrahepatic cholestasis of pregnancy. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01510-w"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhan, Q., Qi, X., Weng, R., Xi, F., Chen, Y., Wang, Y., Hu, W., Zhao, B., and Luo, Q. (2021). Alterations of the Human Gut Microbiota in Intrahepatic Cholestasis of Pregnancy. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.635680"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-023-36981-4","article-title":"Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"108392","DOI":"10.1016\/j.isci.2023.108392","article-title":"Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid\/FXR-FGF15 in rats","volume":"26","author":"Sun","year":"2023","journal-title":"iScience"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4254\/wjh.v16.i4.601","article-title":"Expression and clinical significance of short-chain fatty acids in patients with intrahepatic cholestasis of pregnancy","volume":"16","author":"Ren","year":"2024","journal-title":"World J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10735-025-10387-6","article-title":"Efficacy and mechanism of inhibition of the GPR30-PI3K pathway by 4-phenylbutyric acid in the treatment of intrahepatic cholestasis of pregnancy","volume":"56","author":"Liao","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s10020-025-01215-4","article-title":"BACH1 deficiency improves placental angiogenesis via SLC25A51-mediated mitochondrial NAD(+) transport in intrahepatic cholestasis of pregnancy","volume":"31","author":"Li","year":"2025","journal-title":"Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ren, Y., Shan, X., Ding, G., Ai, L., Zhu, W., Ding, Y., Yu, F., Chen, Y., and Wu, B. (2025). Risk factors and machine learning prediction models for intrahepatic cholestasis of pregnancy. BMC Pregnancy Childbirth, 25.","DOI":"10.1186\/s12884-025-07180-4"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2413854","DOI":"10.1080\/14767058.2024.2413854","article-title":"Predictive efficacy of machine-learning algorithms on intrahepatic cholestasis of pregnancy based on clinical and laboratory indicators","volume":"38","author":"He","year":"2025","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-021-05994-z","article-title":"Intrahepatic cholestasis of pregnancy: Machine-learning algorithm to predict elevated bile acid based on clinical and laboratory data","volume":"304","author":"Asali","year":"2021","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/16\/2002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:45Z","timestamp":1760034465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/16\/2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":114,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["diagnostics15162002"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15162002","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}